Speed Post News Network
New Delhi : The Subject Expert Committee (SEC) in the Central Drugs Standard Control Organisation (CDSCO) met on December 30, 2020, afternoon, to consider the Emergency Use Authorisation (EUA) request of Pfizer, Serum Institute of India (SII), and Bharat Biotech Pvt. Ltd.
Further time was requested on behalf of Pfizer. The additional data and information presented by SII and Bharat Biotech Pvt. Ltd. were perused and analysed by the SEC, according to a PIB release. The analysis of the additional data and information is going on. SEC will meet again on January1, 2021.